Success Stories: An Assistant Research Scientist Acquires NIW and EB1A Cases Approval Just 3 Months Apart, No RFE Issuance
Client’s Testimonial:
“Thank you so much for your exemplary service during the entire process of the filing. I have already referred your firm to many of my colleagues in my university and also to my friends across the USA, a few of them have already been in contract with your firm for filing the petition.”
On February 3rd, 2022 and May 31st, 2022, we received another EB-1A (Alien of Extraordinary Ability) and EB2-NIW (National Interest Waiver) approval for an Assistant Research Scientist in the Field of Infection Biology (Approval Notice).
General Field: Infection Biology
Position at the Time of Case Filing: Assistant Research Scientist
Country of Origin: India
Approval Notice Date: February 3rd, 2022 (EB-1A) and May 31st, 2022 (NIW)
Processing Time: 27 days (EB-1A) (Premium Processing Requested) and 14 months, 22 days (NIW)
Case Summary:
Our client, one of the few leading experts in the infection biology field, approached North America Immigration Law Group to help him establish his consistent and notable record of success and influence in his field of study and his significant contributions to the U.S. by building a strong EB-2 NIW (National Interest Waiver) petition on his behalf.
Since it’s a part of our job to evaluate our client’s qualifications and research background to affirm the veracity of his credentials, we discovered that he is especially well-known for investigating the use of natural products as remedies against cancers and parasitic infections.
Furthermore, his work has been widely cited by many of his peers, with at least 465 citations. After we successfully submitted his achievements for the NIW petition, he also retained our services to collate another petition under the EB-1A (Alien of Extraordinary Ability) visa category. Thus, we agreed to take the case, and we presented his outstanding professional background and unparalleled experience important to his current and future work at USCIS.
Upon reviewing his credentials further, we noted that his research resulted in 19 peer-reviewed scientific articles and 1 book chapter and these papers have been published in some of the most discerning, high-impact journals in his field. Moreover, he has conducted at least 30 reviews for highly acclaimed journals to date. Given its importance, the peer review position is reserved for researchers who have distinguished themselves from their peers through the exceptionally high quality of their published work. For our client to have been entrusted to review the work submitted by his peers, it’s evident that he is widely regarded as a foremost expert in parasitological disciplines and integrated approaches to microbiology.
His case was further backed by including four recommendation letters which he obtained from his fellow experts in the field. One of the recommenders noted the below-mentioned:
“Only a few selected researchers possess the skills and ingenuity to put forward research that addresses the information gaps hindering the discovery of targeted interventions for health conditions, and he is undoubtedly among them. His research on host cell-parasite interactions has provided scientists with essential information for neutralizing neglected parasitic infections, making him an indispensable asset to the U.S.”
Therefore, our objective was to demonstrate our client’s entry to the United States will substantially benefit prospectively the United States by focusing on better understanding persistent Toxoplasma gondii infections in humans, which addresses some of the world’s most pressing issues, including investigating the use of natural products as remedies against cancers and parasitic infections, studying the impact of inflammation and oxidative stress on male infertility, the role of leptin in parasitic infections, and the chronic phase of T. gondii infections.
Furthermore, his study has received funding from the Indian Council of Medical Research (ICMR) and the National Institute of Allergy and Infectious Diseases (NIAID). This funding supports projects that coordinate and promote biomedical research and the development of therapies to treat infectious and immunologic diseases respectively. Accordingly, his research indeed is of vital importance to advancing biomedical research that affects the well-being of individuals on a global scale.
Our team's measures in this case successfully paid off in pursuing USCIS that the rigor of our client’s training and the breadth of his experience have prompted high-impact journals to seek his expertise in the field. We were successful in proving that he is and will continue to be a well-respected and trustworthy infection biology researcher. We would like to congratulate him on securing both the I-140 approvals and a special thanks to the Premium Processing service upgrade for his EB1A case, which was adjudicated in only 27 days instead of 9-12 months. We would also thank him for retaining us for his I-485 application, and we wish him to receive his green card at the earliest.